Status:
COMPLETED
Dermatologists' Educational Demonstration for Epiduo Application
Lead Sponsor:
Seoul National University Hospital
Conditions:
Facial Acne
Local Adverse Effects
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the efficacy and tolerability of this combination gel compared with BPO monotherapy in Korean patients, and test clinical practicability of dermatologists' edu...
Eligibility Criteria
Inclusion
- mild to moderate acne were evaluated by Leeds revised acne grade from 2 to 6
- age: 18-40
Exclusion
- pregnancy
- mental illness
- intake of oral isotretinoin within 6 months
- application of the other oral or topical acne medications
- chemical peeling or light based treatments within 6 weeks.
Key Trial Info
Start Date :
January 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2015
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT02192632
Start Date
January 1 2014
End Date
February 1 2015
Last Update
March 17 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dermatology, Seoul National University
Seoul, Joungro, South Korea, 110-744